372 related articles for article (PubMed ID: 29029885)
21. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
[TBL] [Abstract][Full Text] [Related]
22. Can consolidative thoracic radiotherapy improve outcomes in extensive-disease small cell lung cancer after chemotherapy with complete/near-complete responders?
Kirakli EK; Yilmaz H; Akcay C; Komurcuoglu B; Yilmaz U
J Cancer Res Ther; 2020; 16(4):752-756. PubMed ID: 32930114
[TBL] [Abstract][Full Text] [Related]
23. Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
Bayman E; Etiz D; Akcay M; Ak G
Asian Pac J Cancer Prev; 2014; 15(15):6263-7. PubMed ID: 25124609
[TBL] [Abstract][Full Text] [Related]
24. Thoracic radiation therapy could give survival benefit to elderly patients with extensive-stage small-cell lung cancer.
An C; Jing W; Zhang Y; Liu S; Wang H; Zhu K; Kong L; Guo H; Zhu H
Future Oncol; 2017 Jun; 13(13):1149-1158. PubMed ID: 28326834
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US.
Insinga RP; Vanness DJ; Feliciano JL; Vandormael K; Traore S; Burke T
J Med Econ; 2018 Dec; 21(12):1191-1205. PubMed ID: 30188231
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series.
Gross AJ; Sheikh S; Kharouta M; Chaung K; Choi S; Margevicius S; Fu P; Machtay M; Bruno DS; Dowlati A; Biswas T
Clin Lung Cancer; 2023 Dec; 24(8):696-705. PubMed ID: 37993218
[TBL] [Abstract][Full Text] [Related]
27. Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation.
Zhang H; Deng L; Wang X; Wang D; Teng F; Yu J
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2605-2612. PubMed ID: 31410604
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world.
Fang M; Wang L; Gu Q; Wu H; Du X; Lai X
Clin Exp Metastasis; 2023 Oct; 40(5):423-429. PubMed ID: 37584783
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.
Wu B; Chen H; Shen J; Ye M
Clin Ther; 2011 Oct; 33(10):1446-55. PubMed ID: 21992806
[TBL] [Abstract][Full Text] [Related]
30. Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
Tian S; Zhang X; Jiang R; Pillai RN; Owonikoko TK; Steuer CE; Saba NF; Pakkala S; Patel PR; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M; Higgins KA
Clin Lung Cancer; 2019 Nov; 20(6):484-493.e6. PubMed ID: 31296433
[TBL] [Abstract][Full Text] [Related]
31. Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.
Xu LM; Cheng C; Kang M; Luo J; Gong LL; Pang QS; Wang J; Yuan ZY; Zhao LJ; Wang P
Sci Rep; 2017 Aug; 7(1):9255. PubMed ID: 28835666
[TBL] [Abstract][Full Text] [Related]
32. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer.
Witlox WJA; Ramaekers BLT; Lacas B; Le Pechoux C; Sun A; Wang SY; Hu C; Redman M; van der Noort V; Li N; Guckenberger M; van Tinteren H; Hendriks LEL; Groen HJM; Joore MA; De Ruysscher DKM
Radiother Oncol; 2022 May; 170():95-101. PubMed ID: 35259416
[TBL] [Abstract][Full Text] [Related]
34. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
[TBL] [Abstract][Full Text] [Related]
35. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Kamath SS; McCarley DL; Zlotecki RA
Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
[TBL] [Abstract][Full Text] [Related]
36. Intrathoracic extensive-stage small cell lung cancer: assessment of the benefit of thoracic and brain radiotherapy using the SEER database.
Mahmoud O; Kwon D; Greenfield B; Wright JL; Samuels MA
Int J Clin Oncol; 2016 Dec; 21(6):1062-1070. PubMed ID: 27380168
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective.
Tong YH; Ding HY; Xin WX; Zhong LK; Xu GQ; Zhang B; Yang GN; Fang L
Tumori; 2022 Feb; 108(1):33-39. PubMed ID: 33511911
[TBL] [Abstract][Full Text] [Related]
38. Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US.
Wang Y; Rui M; Yang L; Wang X; Shang Y; Ma A; Li H
Front Public Health; 2021; 9():650392. PubMed ID: 33889559
[No Abstract] [Full Text] [Related]
39. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
Bogart JA; Herndon JE; Lyss AP; Watson D; Miller AA; Lee ME; Turrisi AT; Green MR;
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):460-8. PubMed ID: 15145163
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness analysis of first-line serplulimab combined with chemotherapy for extensive-stage small cell lung cancer.
Liang X; Chen X; Li H; Li Y
Front Public Health; 2023; 11():1156427. PubMed ID: 37727602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
